Publications by authors named "V Y Arion"

Schiff bases derived from aminoguanidine are extensively investigated for their structural versatility. The tridentate 2-formylpyridine guanylhydrazones act as analogues of 2-formyl or 2-acetylpyridine thiosemicarbazones, where the thioamide unit is replaced by the guanidyl group. Six derivatives of 2-formylpyridine guanylhydrazone were synthesized and their proton dissociation and complex formation processes with Cu(II), Fe(II) and Fe(III) ions were studied using pH-potentiometry, UV-visible, NMR and electron paramagnetic resonance spectroscopic methods.

View Article and Find Full Text PDF

Design and development of novel, low-cost and efficient electrocatalysts for oxygen evolution reaction (OER) in alkaline media is crucial for lowering the reaction overpotential and thus decreasing the energy input during the water electrolysis process. Herein, we present the synthesis of new 14-membered bis-thiosemicarbazide and bis-isothiosemicarbazide macrocycles and their nickel(II) complexes characterized by spectroscopic techniques (H and C NMR, IR, UV-vis), electrospray ionization mass spectrometry, single crystal X-ray diffraction, scanning electron microscopy-energy dispersive X-ray spectroscopy (SEM-EDX) and cyclic voltammetry. Finally, the activity of nickel(II) complexes towards OER is reported.

View Article and Find Full Text PDF

Quite recently we discovered that copper(II) complexes with isomeric morpholine-thiosemicarbazone hybrid ligands show good cytotoxicity in cancer cells and that the molecular target responsible for this activity might be tubulin. In order to obtain better lead drug candidates, we opted to exploit the power of coordination chemistry to (i) assemble structures with globular shape to better fit the colchicine pocket and (ii) vary the metal ion. We report the synthesis and full characterization of bis-ligand cobalt(III) and iron(III) complexes with 6-morpholinomethyl-2-formylpyridine 4-(4-hydroxy-3,5-dimethylphenyl)-3-thiosemicarbazone (HL1), 6-morpholinomethyl-2-acetylpyridine 4-(4-hydroxy-3,5-dimethylphenyl)-3-thiosemicarbazone (HL2), and 6-morpholinomethyl-2-formylpyridine 4-phenyl-3-thiosemicarbazone (HL3), and -ligand nickel(II), zinc(II) and palladium(II) complexes with HL1, namely [Co(HL)(L)](NO) (1), [Co(HL)(L)](NO) (2), [Co(HL)(L)](NO) (3), [Fe(L)]NO (4), [Fe(HL)(L)](NO) (5), [Ni(L)]Cl (6), [Zn(L)Cl] (7) and [Pd(HL)Cl]Cl (8).

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates copper(II) thiosemicarbazone complexes as potential anticancer agents, targeting both ribonucleotide reductase (RNR) and tubulin polymerization.
  • The researchers synthesized and characterized four proligands with a methylmorpholine substituent, noting how the position of this group influences the complexes' efficacy against cancer cells.
  • Findings indicate that the complexes effectively inhibit key cancer-related processes, with their antiproliferative activity tied to mechanisms that quench a radical in RNR and impede tubulin polymerization.
View Article and Find Full Text PDF
Article Synopsis
  • Cobalt complexes with specific ligands like PBIT are being studied for their potential in complex catalytic processes.
  • Various methods such as spectroscopy and computational calculations were used to investigate the properties and redox behavior of these complexes.
  • Two specific cobalt complexes showed promise as precatalysts for a Wacker-type oxidation reaction, with insights into their mechanisms and the critical role of phenylsilane and the special characteristics of PBIT.
View Article and Find Full Text PDF